Literature DB >> 25751583

An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research.

Lisa R Norman1, Michael Basso.   

Abstract

Neuropyschological dysfunction, ranging from mild cerebral indicators to dementia has been a consistent part of the medical picture of HIV/AIDS. However, advances in medical supervision, particularly as a result of antiretroviral (ARV) treatment, have resulted in some mitigation of the neuropsychological effects of HIV and necessitate re-evaluation of the pattern and nature of HIV-related cognitive or mental deficits. The associated enhancements in morbidity and mortality that have occurred as a result of ARV medication have led to a need for interventions and programs that maintain behaviors that are healthy and stop the resurgence of the risk of HIV transmission. Risk factors such as mental illness and substance use that may have contributed to the initial infection with HIV still need consideration. These risk factors may also increase neuropsychological dysfunction and impact observance of prevention for treatment and recommendations. Explicitly, a better comprehension of the role of substance use on the progression of HIV-related mental decline can enlighten management and evaluation of persons living with HIV with concurrent disorders of substance use. This review provides a summary of the neurophyschology of substance use and HIV and the existing research that has looked at the effects of both substance use and HIV disease on neurophyscological function and suggestions for future research and treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25751583      PMCID: PMC4900459          DOI: 10.2174/1874473708666150309124820

Source DB:  PubMed          Journal:  Curr Drug Abuse Rev        ISSN: 1874-4737


  267 in total

1.  Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals.

Authors:  M A Cole; J B Margolick; C Cox; X Li; O A Selnes; E M Martin; J T Becker; H A Aronow; B Cohen; N Sacktor; E N Miller
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

Review 2.  The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review.

Authors:  Travis I Lovejoy; Julie A Suhr
Journal:  J Behav Med       Date:  2009-03-17

Review 3.  Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.

Authors:  Anupam Banerjee; Marianne Strazza; Brian Wigdahl; Vanessa Pirrone; Olimpia Meucci; Michael R Nonnemacher
Journal:  J Neurovirol       Date:  2011-07-07       Impact factor: 2.643

4.  Neurocognitive deficits in cocaine users: a quantitative review of the evidence.

Authors:  Diana Jovanovski; Suzanne Erb; Konstantine K Zakzanis
Journal:  J Clin Exp Neuropsychol       Date:  2005-02       Impact factor: 2.475

Review 5.  Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.

Authors:  Mary Jeanne Kreek; Gavin Bart; Charles Lilly; K Steven LaForge; David A Nielsen
Journal:  Pharmacol Rev       Date:  2005-03       Impact factor: 25.468

Review 6.  White matter volume in alcohol use disorders: a meta-analysis.

Authors:  Mollie A Monnig; J Scott Tonigan; Ronald A Yeo; Robert J Thoma; Barbara S McCrady
Journal:  Addict Biol       Date:  2012-03-28       Impact factor: 4.280

7.  Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.

Authors:  Christina S Meade; Nina A Conn; Linda M Skalski; Steven A Safren
Journal:  J Behav Med       Date:  2010-09-21

8.  fMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence.

Authors:  Christina S Meade; Steven B Lowen; Robert R MacLean; Mary D Key; Scott E Lukas
Journal:  Psychiatry Res       Date:  2011-05-04       Impact factor: 3.222

9.  Prefrontal cortex fails to learn from reward prediction errors in alcohol dependence.

Authors:  Soyoung Q Park; Thorsten Kahnt; Anne Beck; Michael X Cohen; Raymond J Dolan; Jana Wrase; Andreas Heinz
Journal:  J Neurosci       Date:  2010-06-02       Impact factor: 6.167

10.  Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain.

Authors:  Govinder Flora; Yong Woo Lee; Avindra Nath; Bernhard Hennig; William Maragos; Michal Toborek
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

View more
  8 in total

Review 1.  [Differential diagnostics of dementia type diseases].

Authors:  W Reith; R Mühl-Benninghaus
Journal:  Radiologe       Date:  2015-05       Impact factor: 0.635

2.  Impaired verbal memory in individuals living with HIV and cocaine dependence.

Authors:  Sarah E Nigro; Minjie Wu; Anthony C Juliano; T Celeste Napier; Alan L Landay; Audrey L French; Shaolin Yang
Journal:  J Clin Exp Neuropsychol       Date:  2022-07-04       Impact factor: 2.283

3.  Differential relationships between cannabis consumption and sleep health as a function of HIV status.

Authors:  Aaron C Lim; April D Thames
Journal:  Drug Alcohol Depend       Date:  2018-09-05       Impact factor: 4.492

4.  Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependence.

Authors:  Nina Pocuca; Jared W Young; David A MacQueen; Scott Letendre; Robert K Heaton; Mark A Geyer; William Perry; Igor Grant; Arpi Minassian
Journal:  Drug Alcohol Depend       Date:  2020-08-22       Impact factor: 4.492

5.  Neuroimaging and Cognitive Evidence for Combined HIV-Alcohol Effects on the Central Nervous System: A Review.

Authors:  Mark K Britton; Eric C Porges; Vaughn Bryant; Ronald A Cohen
Journal:  Alcohol Clin Exp Res       Date:  2020-12-30       Impact factor: 3.928

6.  Syndemic factors associated with adherence to antiretroviral therapy among HIV-positive adult heterosexual men.

Authors:  James M McMahon; Amy Braksmajer; Chen Zhang; Natalie Leblanc; Michael Chen; Angela Aidala; Janie Simmons
Journal:  AIDS Res Ther       Date:  2019-11-09       Impact factor: 2.250

Review 7.  Central Nervous System Effects of COVID-19 in People with HIV Infection.

Authors:  Michael J Peluso; Joanna Hellmuth; Felicia C Chow
Journal:  Curr HIV/AIDS Rep       Date:  2021-11-29       Impact factor: 5.071

8.  Cognitive Decline in Relation to Psychological Wellbeing and HIV Disease- and Treatment Characteristics in HIV-Infected Patients on cART: A One-Year Follow-Up Study.

Authors:  Marloes A M Janssen; Peter P Koopmans; Roy P C Kessels
Journal:  AIDS Behav       Date:  2017-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.